Innovations in serum and urine markers in prostate cancer current European research in the P-Mark project.

Fulltext:
47999schalken.pdf
Embargo:
until further notice
Size:
374.2Kb
Format:
PDF
Description:
publisher's version
Publication year
2005Source
European Urology, 48, 6, (2005), pp. 1031-41ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Urology
Journal title
European Urology
Volume
vol. 48
Issue
iss. 6
Page start
p. 1031
Page end
p. 41
Subject
NCMLS 6: Genetics and epigenetic pathways of disease; ONCOL 3: Translational research; ONCOL 5: Aetiology, screening and detection; UMCN 1.2: Molecular diagnosis, prognosis and monitoringAbstract
An overview is given of serum and urine prostate cancer markers that are currently under investigation and subsequently the P-Mark project is introduced. There are many markers showing promise to overcome the limitations of prostate specific antigen (PSA). Eventually, these markers should be able to increase the specificity in diagnosis, differentiate between harmless and aggressive disease and identify progression towards androgen independence at an early stage. In the P-Mark project, several recently developed, promising markers will be evaluated using clinically well-defined biorepositories. Following successful evaluation, these markers will be validated on a sample set derived from two large, European, prostate cancer studies and used for the identification of special risk groups in the general population. In addition, novel markers will be identified in the same biorepositories by different mass spectrometry techniques.
This item appears in the following Collection(s)
- Academic publications [227437]
- Electronic publications [107154]
- Faculty of Medical Sciences [86157]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.